Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Lactobacillus Fermentum,Inapplicable
Therapeutic Area : Gastroenterology
Study Phase : Phase II
Sponsor : Premier Research Group
Deal Size : Inapplicable
Deal Type : Inapplicable
HEM1036 Phase 2 Study in Low Anterior Resection Syndrome
Details : Undisclosed
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
September 02, 2022
Lead Product(s) : Lactobacillus Fermentum,Inapplicable
Therapeutic Area : Gastroenterology
Highest Development Status : Phase II
Sponsor : Premier Research Group
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Lactobacillus Fermentum,Lactobacillus Delbrueckii
Therapeutic Area : Gastroenterology
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Treatment of Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) With LACTEOL® 340 mg
Details : Undisclosed
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
May 24, 2011
Lead Product(s) : Lactobacillus Fermentum,Lactobacillus Delbrueckii
Therapeutic Area : Gastroenterology
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Lactobacillus Fermentum,Inapplicable
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II/ Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Effect of a Follow on Formula With Lactobacillus Fermentum on the Incidence of Infections
Details : Undisclosed
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
October 06, 2010
Lead Product(s) : Lactobacillus Fermentum,Inapplicable
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II/ Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable